GT
ALXN

Glenmede Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,236
Closed -$1.88M 1367
2021
Q2
$1.88M Sell
10,236
-321
-3% -$58.9K 0.01% 546
2021
Q1
$1.61M Sell
10,557
-66,140
-86% -$10.1M 0.01% 569
2020
Q4
$12M Sell
76,697
-86,165
-53% -$13.5M 0.07% 302
2020
Q3
$18.6M Buy
162,862
+4,951
+3% +$567K 0.11% 207
2020
Q2
$17.7M Sell
157,911
-443,142
-74% -$49.7M 0.11% 231
2020
Q1
$65M Hold
601,053
0.3% 91
2019
Q4
$65M Buy
601,053
+581,631
+2,995% +$62.9M 0.3% 91
2019
Q3
$1.9K Buy
19,422
+12,057
+164% +$1.18K 0.01% 625
2019
Q2
$964 Sell
7,365
-167
-2% -$22 ﹤0.01% 756
2019
Q1
$1.02K Buy
7,532
+2,461
+49% +$332 ﹤0.01% 742
2018
Q4
$491 Buy
5,071
+2,951
+139% +$286 ﹤0.01% 858
2018
Q3
$294K Sell
2,120
-9,739
-82% -$1.35M ﹤0.01% 1025
2018
Q2
$1.47M Buy
11,859
+3,815
+47% +$474K 0.01% 645
2018
Q1
$961K Hold
8,044
﹤0.01% 785
2017
Q4
$961K Sell
8,044
-58
-0.7% -$6.93K ﹤0.01% 785
2017
Q3
$1.14M Buy
8,102
+5,919
+271% +$830K 0.01% 738
2017
Q2
$264K Hold
2,183
﹤0.01% 1118
2017
Q1
$264K Buy
2,183
+138
+7% +$16.7K ﹤0.01% 1118
2016
Q4
$250K Sell
2,045
-863
-30% -$106K ﹤0.01% 1148
2016
Q3
$356K Hold
2,908
﹤0.01% 1019
2016
Q2
$339K Sell
2,908
-169
-5% -$19.7K ﹤0.01% 1033
2016
Q1
$427K Buy
3,077
+849
+38% +$118K ﹤0.01% 961
2015
Q4
$424K Sell
2,228
-40
-2% -$7.61K ﹤0.01% 983
2015
Q3
$354K Sell
2,268
-25
-1% -$3.9K ﹤0.01% 1036
2015
Q2
$413K Hold
2,293
﹤0.01% 1026
2015
Q1
$397K Sell
2,293
-378
-14% -$65.4K ﹤0.01% 1051
2014
Q4
$493K Buy
2,671
+260
+11% +$48K ﹤0.01% 964
2014
Q3
$399K Hold
2,411
﹤0.01% 946
2014
Q2
$375K Hold
2,411
﹤0.01% 973
2014
Q1
$365K Sell
2,411
-64
-3% -$9.69K ﹤0.01% 972
2013
Q4
$328K Sell
2,475
-80
-3% -$10.6K ﹤0.01% 996
2013
Q3
$295K Buy
2,555
+960
+60% +$111K ﹤0.01% 1009
2013
Q2
$146K Buy
+1,595
New +$146K ﹤0.01% 1195